Effect of (R)L-sulforaphane on 5-aminolevulinic acid-mediated photodynamic therapy

Translational Research

Volumn 152, Issue 3, 2008, Pages 128-133

  Mikolajewska, Patrycja ^a,b   Juzeniene, Asta ^a,b   Moan, Johan ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; DIMETHYL SULFOXIDE; PROTOPORPHYRIN; SULFORAPHANE;

ARTICLE; BLEACHING; DRUG EFFECT; DRUG PENETRATION; FLUORESCENCE; HUMAN; HUMAN CELL; PHOTODEGRADATION; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STRATUM CORNEUM; SYNTHESIS;

AMINOLEVULINIC ACID; ANTICARCINOGENIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG STABILITY; HUMANS; PHOTOBLEACHING; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; SKIN; SKIN NEOPLASMS; THIOCYANATES;

EID: 51749091558     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2008.07.004     Document Type: Article

References (38)

1. Angell-Petersen E., Sorensen R., Warloe T., et al. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Invest Dermatol 126 (2006) 265-271
2. Cairnduff F., Stringer M.R., Hudson E.J., Ash D.V., and Brown S.B. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. Br J Cancer 69 (1994) 605-608
3. Chen H.M., Chen C.T., Yang H., et al. Successful treatment of oral verrucous hyperplasia with topical 5-aminolevulinic acid-mediated photodynamic therapy. Oral Oncol 40 (2004) 630-637
4. Braathen L.R., Szeimies R.M., Basset-Seguin N., et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. J Am Acad Dermatol 56 (2007) 125-143
5. Kennedy J.C., and Pottier R.H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 14 (1992) 275-292
6. Marcus S.L., Sobel R.S., Golub A.L., Carroll R.L., Lundahl S., and Shulman D.G. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): current clinical and development status. J Clin Laser Med Surg 14 (1996) 59-66
7. Juzeniene A., Nielsen K.P., and Moan J. Biophysical aspects of photodynamic therapy. J Environ Pathol Toxicol Oncol 25 (2006) 7-28
8. Triesscheijn M., Baas P., Schellens J.H., and Stewart F.A. Photodynamic therapy in oncology. Oncologist 11 (2006) 1034-1044
9. Borelli C., Herzinger T., Merk K., et al. Effect of subcutaneous infiltration anesthesia on pain in photodynamic therapy: a controlled open pilot trial. Dermatol Surg 33 (2007) 314-318
10. Brown S.B., Shillcock M., and Jones P. Equilibrium and kinetic studies of the aggregation of porphyrins in aqueous solution. Biochem J 153 (1976) 279-285
11. Ericson M.B., Sandberg C., Stenquist B., et al. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome. Br J Dermatol 151 (2004) 1204-1212
12. Grapengiesser S., Ericson M., Gudmundsson F., Larko O., Rosen A., and Wennberg A.M. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol 27 (2002) 493-497
13. Holmes M.V., Dawe R.S., Ferguson J., and Ibbotson S.H. A randomized, double-blind, placebo-controlled study of the efficacy of tetracaine gel (Ametop) for pain relief during topical photodynamic therapy. Br J Dermatol 150 (2004) 337-340
14. Kasche A., Luderschmidt S., Ring J., and Hein R. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid. J Drugs Dermatol 5 (2006) 353-356
15. Misra A., Maybury K., and Eltigani T. Late erythema after photodynamic therapy to the face. Plast Reconst Surg 117 (2006) 2522-2523
16. Radakovic-Fijan S., Blecha-Thalhammer U., Kittler H., Honigsmann H., and Tanew A. Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study. J Am Acad Dermatol 53 (2005) 823-827
17. Sandberg C., Stenquist B., Rosdahl I., et al. Important factors for pain during photodynamic therapy for actinic keratosis. Acta Derm Venereol 86 (2006) 404-408
18. Skiveren J., Haedersdal M., Philipsen P.A., Wiegell S.R., and Wulf H.C. Morphine gel 0.3% does not relieve pain during topical photodynamic therapy: a randomized, double-blind, placebo-controlled study. Acta Derm Venereol 86 (2006) 409-411
19. van Oosten E.J., Kuijpers D.I.M., and Thissen M.R.T.M. Different pain sensations in photodynamic therapy of nodular basal cell carcinoma: results from a prospective trial and a review of the literature. Photodiagn Photodyn Ther 3 (2006) 61-68
20. Wennberg A.M. Pain, pain relief and other practical issues in photodynamic therapy. Australas J Dermatol 46 (2005) S3-S4
21. Wiegell S.R., Stender I.M., Na R., and Wulf H.C. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin. Arch Dermatol 139 (2003) 1173-1177
22. Clark C., Dawe R.S., Moseley H., Ferguson J., and Ibbotson S.H. The characteristics of erythema induced by topical 5-aminoleavulinic acid photodynamic therapy. Photodermatol Photoimmunol Photomed 20 (2004) 105-107
23. Fahey J.W., Zhang Y., and Talalay P. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc Natl Acad Sci U S A 94 (1997) 10367-10372
24. Fahey J.W., and Talalay P. Antioxidant functions of sulforaphane: a potent inducer of Phase II detoxication enzymes. Food Chem Toxicol 37 (1999) 973-979
25. Zhang Y., Talalay P., Cho C.G., and Posner G.H. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci U S A 89 (1992) 2399-2403
26. Zhang Y., and Talalay P. Anticarcinogenic activities of organic isothiocyanates: chemistry and mechanisms. Cancer Res 54 (1994) 1976s-1981s
27. Gills J.J., Jeffery E.H., Matusheski N.V., Moon R.C., Lantvit D.D., and Pezzuto J.M. Sulforaphane prevents mouse skin tumorigenesis during the stage of promotion. Cancer Lett 236 (2006) 72-79
28. Yeh C.T., and Yen G.C. Effect of sulforaphane on metallothionein expression and induction of apoptosis in human hepatoma HepG2 cells. Carcinogenesis 26 (2005) 2138-2148
29. Talalay P., Fahey J.W., Healy Z.R., et al. Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation. Proc Natl Acad Sci U S A 104 (2007) 17500-17505
30. Dinkova-Kostova A.T., Fahey J.W., and Wade K.L. Induction of the phase 2 response in mouse and human skin by sylforaphane-containing broccoli sprout extracts. Cancer Epidemiol Biomarkers Prev 16 (2007)
31. Gao X., nkova-Kostova A.T., and Talalay P. Powerful and prolonged protection of human retinal pigment epithelial cells, keratinocytes, and mouse leukemia cells against oxidative damage: the indirect antioxidant effects of sulforaphane. Proc Natl Acad Sci U S A 98 (2001) 15221-15226
32. Talalay P., Fahey J.W., Holtzclaw W.D., Prestera T., and Zhang Y. Chemoprotection against cancer by phase 2 enzyme induction. Toxicol Lett 82-83 (1995) 173-179
33. Choi W.Y., Choi B.T., Lee W.H., and Choi Y.H. Sulforaphane generates reactive oxygen species leading to mitochondrial perturbation for apoptosis in human leukemia U937 cells. Biomed Pharmacother (2008) 1-8
34. Yeh C.T., and Yen G.C. Effect of sulforaphane on metallothionein expression and induction of apoptosis in human hepatoma HepG2 cells. Carcinogenesis 26 (2005) 2138-2148
35. Sikorski E.M., Hock T., Hill-Kapturczak N., and Agarwal A. The story so far: molecular regulation of the heme oxygenase-1 gene in renal injury. Am J Physiol Renal Physiol 286 (2004) F425-F441
36. Zhang J., and Piantadosi C.A. Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain. J Clin Invest 90 (1992) 1193-1199
37. Dennery P.A., Seidman D.S., and Stevenson D.K. Neonatal hyperbilirubinemia. N Engl J Med 344 (2001) 581-590
38. Notman R., den Otter W.K., Noro M.G., Briels W.J., and Anwar J. The permeability enhancing mechanism of DMSO in ceramide bilayers simulated by molecular dynamics. Biophys J 93 (2007) 2056-2068